ArticleJournal of the Endocrine Society2021

PCSK-9 Inhibitors in a Real-World Setting and a Comparison Between Alirocumab and Evolocumab in Heterozygous FH Patients.

José Juan Ceballos-Macías et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.